Business Context and Reporting Period
This Form 6-K filing by Tiziana Life Sciences plc (the "Company") is dated April 14, 2020. The report discloses the entry into an "At-The-Market" (ATM) Sales Agreement on April 10, 2020, with Thinkequity, a division of Fordham Financial Management, Inc., to facilitate the sale of American Depositary Shares (ADSs).
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or debt figures. The primary financial metric disclosed is the potential capital raise:
- Aggregate Offering Price: Up to $20 million.
- Security Type: American Depositary Shares (ADSs), each representing five ordinary shares with a nominal value of £0.03.
- Commission Rate: 2.5% of aggregate gross proceeds payable to the sales agent.
Material Changes
The material change reported is the establishment of a new equity financing facility. The Company has authorized the sale of ADSs through an ATM program, allowing for flexible issuance based on market conditions. This agreement supersedes any prior similar arrangements for this specific tranche and is governed by a shelf registration statement (File No. 333-236013) declared effective on February 6, 2020.
Guidance, Outlook, and Risks
Management Commentary and Terms:
- Sales will be conducted at market prices or as otherwise agreed, subject to instructions from the Company regarding price or size limits.
- The Company is not obligated to sell any ADSs under the agreement.
- The offering will terminate on the earliest of: (a) sale of all ADSs, (b) termination by either party, or (c) June 11, 2020.
Risks and Contingencies:
- The filing explicitly states it does not constitute an offer to sell securities in any state where such an offer would be unlawful prior to registration.
- The Company has agreed to provide customary indemnification and contribution rights to Thinkequity and reimburse specified expenses.
Investor Verification Checklist
- Verify the current market price of Tiziana Life Sciences ADSs to assess the potential dilution impact of a $20 million raise.
- Review the full text of the ATM Sales Agreement (Exhibit 1.1) for specific termination clauses and price limitations.
- Confirm the Company's current cash position and burn rate to understand the urgency of this capital raise.
- Check subsequent filings to determine if any sales have been executed under this agreement prior to the June 11, 2020 termination date.